Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Intergroupe Francophone du Myelome
Philippe Moreau; Michel Attal; Cyrille Hulin; Bertrand Arnulf; Karim Belhadj; Lotfi Benboubker; Marie C Béné; Annemiek Broijl; Hélène Caillon; Denis Caillot; Jill Corre; Michel Delforge; Thomas Dejoie; Chantal Doyen; Thierry Facon; Cécile Sonntag; Jean Fontan; Laurent Garderet; Kon-Siong Jie; Lionel Karlin; Frédérique Kuhnowski; Jérôme Lambert; Xavier Leleu; Pascal Lenain; Margaret Macro; Claire Mathiot; Frédérique Orsini-Piocelle; Aurore Perrot; Anne-Marie Stoppa; Niels Wcj van de Donk; Soraya Wuilleme; Sonja Zweegman; Brigitte Kolb; Cyrille Touzeau; Murielle Roussel; Mourad Tiab; Jean-Pierre Marolleau; Nathalie Meuleman; Marie-Christiane Vekemans; Matthijs Westerman; Saskia K Klein; Mark-David Levin; Jean Paul Fermand; Martine Escoffre-Barbe; Jean-Richard Eveillard; Reda Garidi; Tahamtan Ahmadi; Sen Zhuang; Christopher Chiu; Lixia Pei; Carla de Boer; Elena Smith; William Deraedt; Tobias Kampfenkel; Jordan Schecter; Jessica Vermeulen; Hervé Avet-Loiseau; Pieter Sonneveld
Biostatistical Department, Hôpital Saint Louis, Paris, France.